Imricor Medical Systems Inc. (ASX:IMR) Share Price & Analysis
(ASX:IMR) Share Price Chart
About (ASX: IMR)
Imricor Medical Systems is a pioneering medical technology company specializing in developing innovative MRI-compatible products for cardiac ablation procedures. Founded in 2006, the company has established itself as the first and only provider of commercially viable and safe imaging catheter (iCMR) products designed to be used during magnetic resonance imaging (MRI) scans.
The company’s core product lineup includes the Vision-MR Ablation Catheter 2.0, Vision-MR Diagnostic Catheter, Advantage-MR EP Recorder/Stimulator, and the NorthStar Mapping System. These groundbreaking medical devices enable physicians to perform cardiac ablation procedures directly inside an MRI, offering unprecedented real-time imaging and precision for treating heart rhythm disorders. By integrating MRI technology with interventional cardiology, Imricor is transforming how complex cardiac procedures are performed.
Publicly traded on the Australian Securities Exchange (ASX:IMR), Imricor is committed to advancing electrophysiology by providing cutting-edge medical technology that enhances patient outcomes and surgical capabilities. The company has a global presence and continues to drive innovation in MRI-guided medical interventions, with a focus on developing safe, effective, and technologically advanced solutions for cardiac medical professionals.